NASDAQ:ZYME
Zymeworks Inc.
Zymeworks Inc.'s revenue grew 38.9% in fiscal 2025 to $106.0M while operating margin rose to −87.3%. Free cash flow was −$34.5M, −32.6% of revenue, and the diluted share count fell 0.6%.Summary generated from Zymeworks Inc.'s SEC filings. Latest annual report filed Mar 2, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$106.0M
Revenue growth+38.9%
Revenue, 5-yr CAGR+22.2%
Gross marginn/a
Operating margin−87.3%
Net margin−76.6%
ROICn/a
Return on equity−26.7%
Debt / equityn/a
Free cash flow−$34.5M
FCF margin−32.6%
Share count change−0.6%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 27 | 412 | 76 | 76 | 106 |
| Operating income | −216 | 131 | −138 | −137 | −93 |
| Net income | −212 | 124 | −119 | −123 | −81 |
| Free cash flow | −205 | 136 | −121 | −112 | −35 |
Recent filings
- 4Insider transaction report
Oct 9, 2026 - 8-KEntry into a material agreement
Sep 23, 2026 - 8-KRegulation FD disclosure
Aug 25, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 4Insider transaction report
Jul 6, 2026 - 8-KEntry into a material agreement
Jun 29, 2026 - 8-KRegulation FD disclosure
May 14, 2026